4.5 Article

Spectrum of movement disorders and motor abnormalities in adults with a 22q11.2 microdeletion: Comment on the literature and retrospective study of 92 adults

Journal

EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 30, Issue 12, Pages 1314-1317

Publisher

SPRINGERNATURE
DOI: 10.1038/s41431-022-01152-4

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Educational

Sexual knowledge and behaviour in 22q11.2 deletion syndrome, a complex care condition

Lisa D. Palmer, Tracy Heung, Maria Corral, Erik Boot, Stephanie G. Brooks, Anne S. Bassett

Summary: This study found that the majority of adults with 22q11.2 deletion syndrome had sexual knowledge deficits, and most of those who were sexually active engaged in high-risk sexual behaviors.

JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES (2022)

Review Genetics & Heredity

Ocular findings in 22q11.2 deletion syndrome: A systematic literature review and results of a Dutch multicenter study

Emma N. M. M. von Scheibler, Emy S. van der Valk Bouman, Myrthe A. Nuijts, Noel J. C. Bauer, Tos T. J. M. Berendschot, Pit Vermeltfoort, Levinus A. Bok, Agnies M. van Eeghen, Michiel L. Houben, Therese A. M. J. van Amelsvoort, Erik Boot, Michelle B. van Egmond-Ebbeling

Summary: 22q11.2DS patients commonly exhibit ocular manifestations such as retinal vascular tortuosity, posterior embryotoxon, eye lid hooding, strabismus, amblyopia, ptosis, and refractive errors. Most patients have normal or near-normal visual acuity, but refractive errors, strabismus, and amblyopia require early correction.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2022)

Article Psychiatry

Elevated regional cerebral blood flow in adults with 22q11.2 deletion syndrome

Maurice Pasternak, Zahra Shirzadi, Henk J. M. M. Mutsaerts, Erik Boot, Nancy J. Butcher, Bradley J. MacIntosh, Tracy Heung, Anne S. Bassett, Mario Masellis

Summary: This study used arterial spin labelling MRI to investigate differences in cerebral blood flow between individuals with 22q11DS and healthy controls. The results showed significantly elevated cerebral blood flow in specific brain regions of 22q11DS individuals, suggesting possible relevance to schizophrenia risk and highlighting the importance of further functional neuroimaging studies with larger sample sizes.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2023)

Article Psychiatry

Post-traumatic stress in adults with 22q11.2 deletion syndrome

Emma N. M. M. von Scheibler, Therese A. M. J. van Amelsvoort, Claudia Vingerhoets, Agnies M. van Eeghen, Erik Boot

Summary: The prevalence of PTSD in individuals with 22q11.2 deletion syndrome may be underdiagnosed, according to our study. Our findings emphasize the importance of being alert to trauma in this population for timely treatment and minimizing psychiatric burden.

BJPSYCH OPEN (2022)

Review Clinical Neurology

Parkinsonism in Genetic Neurodevelopmental Disorders: A Systematic Review

Emma N. M. M. von Scheibler, Agnies M. van Eeghen, Tom J. de Koning, Mark L. Kuijf, Janneke R. Zinkstok, Annelieke R. Muller, Therese A. M. J. van Amelsvoort, Erik Boot

Summary: This review examines the association between genetic neurodevelopmental disorders and parkinsonism, providing an overview of genetic diagnosis, clinical features, and proposed disease mechanisms. The findings indicate that parkinsonism is reported in various genetic neurodevelopmental disorders and offer insights for further research and patient management.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Review Genetics & Heredity

Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome

Erik Boot, Solveig Oskarsdottir, Joanne C. Y. Loo, Terrence Blaine Crowley, Ani Orchanian-Cheff, Danielle M. Andrade, Jill M. Arganbright, Rene M. Castelein, Christine Cserti-Gazdewich, Steven de Reuver, Ania M. Fiksinski, Gunilla Klingberg, Anthony E. Lang, Maria R. Mascarenhas, Edward M. Moss, Beata Anna Nowakowska, Erwin Oechslin, Lisa Palmer, Gabriela M. Repetto, Nikolai Gil D. Reyes, Maude Schneider, Candice Silversides, Kathleen E. Sullivan, Ann Swillen, Therese A. M. J. van Amelsvoort, Jason P. Van Batavia, Claudia Vingerhoets, Donna M. McDonald-McGinn, Anne S. Bassett

Summary: The clinical practice guidelines for managing adults with 22q11.2 deletion syndrome (22q11.2DS) were updated through a stepwise process involving expert clinicians worldwide. The recommendations were formulated based on systematic literature review, clinical expert synthesis, and patient advocate survey results. The limited evidence base necessitates multidisciplinary recommendations as the current best practice in this evolving field.

GENETICS IN MEDICINE (2023)

Review Genetics & Heredity

Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome

Solveig Oskarsdottir, Erik Boot, Terrence Blaine Crowley, Joanne C. Y. Loo, Jill M. Arganbright, Marco Armando, Adriane L. Baylis, Elemi J. Breetvelt, Rene M. Castelein, Madeline Chadehumbe, Christopher M. Cielo, Steven de Reuver, Stephan Eliez, Ania M. Fiksinski, Brian J. Forbes, Emily Gallagher, Sarah E. Hopkins, Oksana A. Jackson, Lorraine Levitz-Katz, Gunilla Klingberg, Michele P. Lambert, Bruno Marino, Maria R. Mascarenhas, Julie Moldenhauer, Edward M. Moss, Beata Anna Nowakowska, Ani Orchanian-Cheff, Carolina Putotto, Gabriela M. Repetto, Erica Schindewolf, Maude Schneider, Cynthia B. Solot, Kathleen E. Sullivan, Ann Swillen, Marta Unolt, Jason P. Van Batavia, Claudia Vingerhoets, Jacob Vorstman, Anne S. Bassett, Donna M. McDonald-McGinn

Summary: This review aimed to update the clinical practice guidelines for managing children and adolescents with 22q11.2 deletion syndrome (22q11.2DS). The process involved systematic literature search, data extraction, and consensus drafting based on expert opinion and feedback from family support organizations. The recommendations provide contemporary guidance for the evaluation, surveillance, and management of the various morbidities associated with 22q11.2DS while addressing genetic counseling and psychosocial issues.

GENETICS IN MEDICINE (2023)

Article Genetics & Heredity

Prenatal Screening and Diagnostic Considerations for 22q11.2 Microdeletions

Natalie Blagowidow, Beata Nowakowska, Erica Schindewolf, Francesca Romana Grati, Carolina Putotto, Jeroen Breckpot, Ann Swillen, Terrence Blaine Crowley, Joanne C. Y. Loo, Lauren A. Lairson, Solveig Oskarsdottir, Erik Boot, Sixto Garcia-Minaur, Maria Cristina Digilio, Bruno Marino, Beverly Coleman, Julie S. Moldenhauer, Anne S. Bassett, Donna M. McDonald-McGinn

Summary: Early diagnosis of chromosome 22q11.2 microdeletion and its associated deletion syndrome is important. Prenatal diagnostic testing is recommended for parents or children with the microdeletion or suggestive prenatal screening results. Genetic testing using a chromosomal microarray can detect clinically relevant microdeletions. Noninvasive prenatal screening and imaging are available screening options. NIPS has a high detection rate, while prenatal imaging can detect physical features associated with the syndrome.

GENES (2023)

Article Genetics & Heredity

Gathering the Stakeholder's Perspective: Experiences and Opportunities in Rare Genetic Disease Research

Lauren K. White, T. Blaine Crowley, Brenda Finucane, Emily J. McClellan, Sarah Donoghue, Sixto Garcia-Minaur, Gabriela M. Repetto, Matthias Fischer, Sebastien Jacquemont, Raquel E. Gur, Anne M. Maillard, Kirsten A. Donald, Anne S. Bassett, Ann Swillen, Donna M. McDonald-McGinn

Summary: This study investigated the motivation and opinions of individuals and caregivers affected by CNVs regarding research participation. It also examined their feelings of preparedness, research burden, and satisfaction. Results showed that education and altruism were the top reasons for participation, while treatment risks and side effects were the main reasons for withdrawal. Most participants reported positive research experiences.

GENES (2023)

Article Genetics & Heredity

Hearing loss and history of otolaryngological conditions in adults with microdeletion 22q11.2

Emma N. M. M. von Scheibler, Josine C. C. Widdershoven, Denise C. P. B. M. van Barneveld, Nina Schroder, Agnies M. van Eeghen, Therese A. M. J. van Amelsvoort, Erik Boot

Summary: This study reports on hearing loss and otolaryngological conditions in adults with 22q11.2DS. The results suggest that high-frequency hearing loss is common in this population and is associated with older age and a history of chronic otitis media. The study also identified several otolaryngological conditions that may require treatment.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2023)

Review Genetics & Heredity

Psychiatric and neurological manifestations in adults with Smith-Magenis syndrome: A scoping review

Dorinde Korteling, Jiska L. I. Musch, Janneke R. Zinkstok, Erik Boot

Summary: Smith-Magenis syndrome (SMS) is a neurodevelopmental disorder caused by a genetic deletion or variant in the RAI1 gene. A comprehensive review of the literature on adults with SMS revealed that many manifestations from childhood persist into adulthood. Adults with SMS commonly experience intellectual disability, autism spectrum and attention deficit hyperactivity disorder features, self-injurious and physical aggressive behaviors, sleep-wake disorders, and seizures. This review provides valuable insights for optimizing management strategies and investigating late-onset psychiatric and neurological comorbidities in SMS.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2023)

Article Genetics & Heredity

Intellectual and Behavioral Phenotypes of Smith-Magenis Syndrome: Comparisons between Individuals with a 17p11.2 Deletion and Pathogenic RAI1 Variant

Cathelijne C. Linders, Agnies M. van Eeghen, Janneke R. Zinkstok, Marie-Jose van den Boogaard, Erik Boot, Xingguang Luo

Summary: This study compared the effects of 17p11.2 deletion and pathogenic RAI1 variants on intellectual and behavioral phenotypes. The results showed that individuals with 17p11.2 deletions had lower IQ scores and more behavioral problems, while those with RAI1 variants had higher levels of internalizing problems. These findings may contribute to personalized management strategies for individuals with Smith-Magenis syndrome.

GENES (2023)

No Data Available